Zhang Y, Shen L, Dreissigacker K, Zhu H, et al. Targeting of canonical WNT signaling ameliorates experimental sclerodermatous chronic graft-versus-host disease. Blood 2021 Feb 2. pii: 475143. doi: 10.1182/blood.2020008720.
PMID: 33529322